Cargando…
Fasting cycles potentiate the efficacy of gemcitabine treatment in in vitro and in vivo pancreatic cancer models
BACKGROUND/AIMS: Pancreatic cancer (PC) is ranked as the fourth leading cause of cancer-related deaths worldwide. Despite recent advances in treatment options, a modest impact on the outcome of the disease is observed so far. Short-term fasting cycles have been shown to potentiate the efficacy of ch...
Autores principales: | D'Aronzo, Martina, Vinciguerra, Manlio, Mazza, Tommaso, Panebianco, Concetta, Saracino, Chiara, Pereira, Stephen P., Graziano, Paolo, Pazienza, Valerio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621909/ https://www.ncbi.nlm.nih.gov/pubmed/26176887 |
Ejemplares similares
-
SIRT1-metabolite binding histone macroH2A1.1 protects hepatocytes against lipid accumulation
por: Pazienza, Valerio, et al.
Publicado: (2014) -
Engineered Resistant-Starch (ERS) Diet Shapes Colon Microbiota Profile in Parallel with the Retardation of Tumor Growth in In Vitro and In Vivo Pancreatic Cancer Models
por: Panebianco, Concetta, et al.
Publicado: (2017) -
Improving Gemcitabine Sensitivity in Pancreatic Cancer Cells by Restoring miRNA-217 Levels
por: Panebianco, Concetta, et al.
Publicado: (2021) -
High Levels of Prebiotic Resistant Starch in Diet Modulate Gene Expression and Metabolomic Profile in Pancreatic Cancer Xenograft Mice
por: Panebianco, Concetta, et al.
Publicado: (2019) -
Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients
por: Tavano, Francesca, et al.
Publicado: (2014)